Cargando…
Antiosteoporosis medications and cardiovascular disease: a population-based nationwide nested case–control study
Purpose: Patients with osteoporosis are at an increased risk of cardiovascular disease (CVD). Several antiosteoporosis medications have been demonstrated with the benefit of preventing osteoporosis. Our aim is to assess the CVD risks associated with antiosteoporosis medications using the National He...
Autores principales: | Tsai, Wen-Hsuan, Sung, Fung-Chang, Muo, Chih-Hsin, Tsai, Ming-Chieh, Wu, Shu-I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10595014/ https://www.ncbi.nlm.nih.gov/pubmed/37881187 http://dx.doi.org/10.3389/fphar.2023.1220174 |
Ejemplares similares
-
Decreased Risk of Anxiety in Diabetic Patients Receiving Glucagon-like Peptide-1 Receptor Agonist: A Nationwide, Population-Based Cohort Study
por: Tsai, Wen-Hsuan, et al.
Publicado: (2022) -
Corrigendum: Decreased Risk of Anxiety in Diabetic Patients Receiving Glucagon-Like Peptide-1 Receptor Agonist: A Nationwide, Population-Based Cohort Study
por: Tsai, Wen-Hsuan, et al.
Publicado: (2022) -
Statin Therapy for Hyperlipidemic Patients With Chronic Kidney Disease and End-Stage Renal Disease: A Retrospective Cohort Study Based on 925,418 Adults in Taiwan
por: Sung, Fung-Chang, et al.
Publicado: (2022) -
Antiosteoporosis effect of tanshinol in osteoporosis animal models: A systematic review and meta-analysis
por: Wang, Shen, et al.
Publicado: (2022) -
The Ginsenoside Exhibits Antiosteoporosis Effects in Ketogenic-Diet-Induced Osteoporosis via Rebalancing Bone Turnover
por: Liu, Qi, et al.
Publicado: (2021)